Multicenter Study
An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group.
Diabetes Care. 1996 Oct 1;19(10):1051-61.
Article
PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.
Diabet. Med. 2007 Sep 1;24(9):982-1002.
Review
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
Health Technol Assess. 2006 Aug 1;10(27):iii-iv, ix-xi, 1-164.